Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Elastic behavior of model membranes with antimicrobial peptides depends on lipid specificity and d-enantiomers.

Kumagai A, Dupuy FG, Arsov Z, Elhady Y, Moody D, Ernst RK, Deslouches B, Montelaro RC, Peter Di Y, Tristram-Nagle S.

Soft Matter. 2019 Feb 20;15(8):1860-1868. doi: 10.1039/c8sm02180e.

PMID:
30702120
2.

Enhanced biofilm prevention activity of a SPLUNC1-derived antimicrobial peptide against Staphylococcus aureus.

Yu Z, Deslouches B, Walton WG, Redinbo MR, Di YP.

PLoS One. 2018 Sep 14;13(9):e0203621. doi: 10.1371/journal.pone.0203621. eCollection 2018.

3.

Antimicrobial Peptides: A Potential Therapeutic Option for Surgical Site Infections.

Deslouches B, Di YP.

Clin Surg. 2017 Nov;2. pii: 1740. Epub 2017 Nov 16.

4.

Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37.

Lin Q, Deslouches B, Montelaro RC, Di YP.

Int J Antimicrob Agents. 2018 Nov;52(5):667-672. doi: 10.1016/j.ijantimicag.2018.04.019. Epub 2018 May 10.

PMID:
29753132
5.

Elimination of Antibiotic Resistant Surgical Implant Biofilms Using an Engineered Cationic Amphipathic Peptide WLBU2.

Mandell JB, Deslouches B, Montelaro RC, Shanks RMQ, Doi Y, Urish KL.

Sci Rep. 2017 Dec 22;7(1):18098. doi: 10.1038/s41598-017-17780-6.

6.

Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia.

Chen C, Deslouches B, Montelaro RC, Di YP.

Clin Microbiol Infect. 2018 May;24(5):547.e1-547.e8. doi: 10.1016/j.cmi.2017.08.029. Epub 2017 Sep 4.

PMID:
28882728
7.

Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.

Deslouches B, Di YP.

Oncotarget. 2017 Jul 11;8(28):46635-46651. doi: 10.18632/oncotarget.16743. Review.

8.

Simultaneous Antibiofilm and Antiviral Activities of an Engineered Antimicrobial Peptide during Virus-Bacterium Coinfection.

Melvin JA, Lashua LP, Kiedrowski MR, Yang G, Deslouches B, Montelaro RC, Bomberger JM.

mSphere. 2016 May 4;1(3). pii: e00083-16. doi: 10.1128/mSphere.00083-16. eCollection 2016 May-Jun.

9.

Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.

Lashua LP, Melvin JA, Deslouches B, Pilewski JM, Montelaro RC, Bomberger JM.

J Antimicrob Chemother. 2016 Aug;71(8):2200-7. doi: 10.1093/jac/dkw143. Epub 2016 May 26.

10.

Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.

Deslouches B, Hasek ML, Craigo JK, Steckbeck JD, Montelaro RC.

J Med Microbiol. 2016 Jun;65(6):554-65. doi: 10.1099/jmm.0.000258. Epub 2016 Apr 5.

11.

Novel engineered cationic antimicrobial peptides display broad-spectrum activity against Francisella tularensis, Yersinia pestis and Burkholderia pseudomallei.

Abdelbaqi S, Deslouches B, Steckbeck J, Montelaro R, Reed DS.

J Med Microbiol. 2016 Feb;65(2):188-94. doi: 10.1099/jmm.0.000209. Epub 2015 Dec 15.

PMID:
26673248
12.

Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.

Quinn M, Turula H, Tandon M, Deslouches B, Moghbeli T, Snyder CM.

J Immunol. 2015 Feb 15;194(4):1726-1736. doi: 10.4049/jimmunol.1402757. Epub 2015 Jan 16.

13.

Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens.

Deslouches B, Steckbeck JD, Craigo JK, Doi Y, Burns JL, Montelaro RC.

Antimicrob Agents Chemother. 2015 Feb;59(2):1329-33. doi: 10.1128/AAC.03937-14. Epub 2014 Nov 24.

14.

Antimicrobial peptides: new drugs for bad bugs?

Steckbeck JD, Deslouches B, Montelaro RC.

Expert Opin Biol Ther. 2014 Jan;14(1):11-4. doi: 10.1517/14712598.2013.844227. Epub 2013 Nov 11. Review.

15.

Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens.

Deslouches B, Steckbeck JD, Craigo JK, Doi Y, Mietzner TA, Montelaro RC.

Antimicrob Agents Chemother. 2013 Jun;57(6):2511-21. doi: 10.1128/AAC.02218-12. Epub 2013 Mar 18.

17.

De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia.

Deslouches B, Gonzalez IA, DeAlmeida D, Islam K, Steele C, Montelaro RC, Mietzner TA.

J Antimicrob Chemother. 2007 Sep;60(3):669-72. Epub 2007 Jul 10.

18.

Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.

Deslouches B, Islam K, Craigo JK, Paranjape SM, Montelaro RC, Mietzner TA.

Antimicrob Agents Chemother. 2005 Aug;49(8):3208-16.

19.

Antimicrobial peptides in mucosal secretions: the importance of local secretions in mitigating infection.

Phadke SM, Deslouches B, Hileman SE, Montelaro RC, Wiesenfeld HC, Mietzner TA.

J Nutr. 2005 May;135(5):1289-93.

PMID:
15867326
20.

De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.

Deslouches B, Phadke SM, Lazarevic V, Cascio M, Islam K, Montelaro RC, Mietzner TA.

Antimicrob Agents Chemother. 2005 Jan;49(1):316-22.

21.

Selective toxicity of engineered lentivirus lytic peptides in a CF airway cell model.

Phadke SM, Islam K, Deslouches B, Kapoor SA, Beer Stolz D, Watkins SC, Montelaro RC, Pilewski JM, Mietzner TA.

Peptides. 2003 Aug;24(8):1099-107.

PMID:
14612179
22.

A heme-deficient strain of Escherichia coli has a three-base pair deletion in a "hotspot" in hemA.

Li J, Deslouches B, Cosloy SD, Russell CS.

Biochim Biophys Acta. 2003 Apr 15;1626(1-3):102-5.

PMID:
12697336

Supplemental Content

Loading ...
Support Center